These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23990460)

  • 1. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
    Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
    J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.
    Cierpicki T; Risner LE; Grembecka J; Lukasik SM; Popovic R; Omonkowska M; Shultis DD; Zeleznik-Le NJ; Bushweller JH
    Nat Struct Mol Biol; 2010 Jan; 17(1):62-8. PubMed ID: 20010842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1.
    Frauer C; Rottach A; Meilinger D; Bultmann S; Fellinger K; Hasenöder S; Wang M; Qin W; Söding J; Spada F; Leonhardt H
    PLoS One; 2011 Feb; 6(2):e16627. PubMed ID: 21311766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
    Ayton PM; Chen EH; Cleary ML
    Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains.
    Jørgensen HF; Ben-Porath I; Bird AP
    Mol Cell Biol; 2004 Apr; 24(8):3387-95. PubMed ID: 15060159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular coupling of DNA methylation and histone methylation.
    Hashimoto H; Vertino PM; Cheng X
    Epigenomics; 2010 Oct; 2(5):657-69. PubMed ID: 21339843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
    Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2.
    Bach C; Mueller D; Buhl S; Garcia-Cuellar MP; Slany RK
    Oncogene; 2009 Feb; 28(6):815-23. PubMed ID: 19060922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
    Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
    Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.
    Kuntimaddi A; Achille NJ; Thorpe J; Lokken AA; Singh R; Hemenway CS; Adli M; Zeleznik-Le NJ; Bushweller JH
    Cell Rep; 2015 May; 11(5):808-20. PubMed ID: 25921540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase.
    Allen MD; Grummitt CG; Hilcenko C; Min SY; Tonkin LM; Johnson CM; Freund SM; Bycroft M; Warren AJ
    EMBO J; 2006 Oct; 25(19):4503-12. PubMed ID: 16990798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.
    Fujita N; Takebayashi S; Okumura K; Kudo S; Chiba T; Saya H; Nakao M
    Mol Cell Biol; 1999 Sep; 19(9):6415-26. PubMed ID: 10454587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications.
    Stroynowska-Czerwinska A; Piasecka A; Bochtler M
    Biochim Biophys Acta Gene Regul Mech; 2018 Dec; 1861(12):1093-1101. PubMed ID: 30352306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
    Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
    Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
    Ropa J; Saha N; Hu H; Peterson LF; Talpaz M; Muntean AG
    Haematologica; 2020 Sep; 105(9):2273-2285. PubMed ID: 33054052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.
    Nguyen AT; Taranova O; He J; Zhang Y
    Blood; 2011 Jun; 117(25):6912-22. PubMed ID: 21521783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
    Wang WT; Chen TQ; Zeng ZC; Pan Q; Huang W; Han C; Fang K; Sun LY; Yang QQ; Wang D; Luo XQ; Sun YM; Chen YQ
    J Hematol Oncol; 2020 Jun; 13(1):78. PubMed ID: 32552847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFP1 interacts with DNMT1 independently of association with the Setd1 Histone H3K4 methyltransferase complexes.
    Butler JS; Lee JH; Skalnik DG
    DNA Cell Biol; 2008 Oct; 27(10):533-43. PubMed ID: 18680430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL is essential for NUP98-HOXA9-induced leukemia.
    Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
    Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.